These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 12200627)

  • 1. Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process.
    Togo T; Dickson DW
    Acta Neuropathol; 2002 Oct; 104(4):398-402. PubMed ID: 12200627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laminar distribution of the pathological changes in frontal and temporal cortex in 8 patients with progressive supranuclear palsy.
    Armstrong RA; Cairns NJ
    Clin Neuropathol; 2009; 28(5):350-7. PubMed ID: 19788050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lewy bodies in progressive supranuclear palsy represent an independent disease process.
    Uchikado H; DelleDonne A; Ahmed Z; Dickson DW
    J Neuropathol Exp Neurol; 2006 Apr; 65(4):387-95. PubMed ID: 16691119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astrocytic tau pathology positively correlates with neurofibrillary tangle density in progressive supranuclear palsy.
    Ito K; Arai K; Yoshiyama Y; Kashiwado K; Sakakibara Y; Hattori T
    Acta Neuropathol; 2008 Jun; 115(6):623-8. PubMed ID: 18427815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuft-shaped astrocytes in Lewy body disease.
    Hishikawa N; Hashizume Y; Yoshida M; Niwa J; Tanaka F; Sobue G
    Acta Neuropathol; 2005 Apr; 109(4):373-80. PubMed ID: 15668789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatial patterns of the tau pathology in progressive supranuclear palsy.
    Armstrong RA; Cairns NJ
    Neurol Sci; 2013 Mar; 34(3):337-44. PubMed ID: 22411688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive supranuclear palsy presenting with primary progressive aphasia--clinicopathological report of an autopsy case.
    Mochizuki A; Ueda Y; Komatsuzaki Y; Tsuchiya K; Arai T; Shoji S
    Acta Neuropathol; 2003 Jun; 105(6):610-4. PubMed ID: 12669238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Abeta, tau and alpha-synuclein and glial cells].
    Akiyama H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Feb; 26(1):23-31. PubMed ID: 16637593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortical degeneration in progressive supranuclear palsy. A comparison with cortical-basal ganglionic degeneration.
    Bergeron C; Pollanen MS; Weyer L; Lang AE
    J Neuropathol Exp Neurol; 1997 Jun; 56(6):726-34. PubMed ID: 9184663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexistence of PSP and MSA: a case report and review of the literature.
    Uchikado H; DelleDonne A; Uitti R; Dickson DW
    Acta Neuropathol; 2006 Feb; 111(2):186-92. PubMed ID: 16456665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frontotemporal dementia with co-occurrence of astrocytic plaques and tufted astrocytes, and severe degeneration of the cerebral white matter: a variant of corticobasal degeneration?
    Tan CF; Piao YS; Kakita A; Yamada M; Takano H; Tanaka M; Mano A; Makino K; Nishizawa M; Wakabayashi K; Takahashi H
    Acta Neuropathol; 2005 Mar; 109(3):329-38. PubMed ID: 15841415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy.
    Katsuse O; Iseki E; Arai T; Akiyama H; Togo T; Uchikado H; Kato M; de Silva R; Lees A; Kosaka K
    Acta Neuropathol; 2003 Sep; 106(3):251-60. PubMed ID: 12802605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characterization of glial fibrillary tangles in progressive supranuclear palsy and Alzheimer's disease].
    Nishimura M
    No To Shinkei; 1996 Oct; 48(10):895-903. PubMed ID: 8921528
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary progressive aphasia as the initial manifestation of corticobasal degeneration and unusual tauopathies.
    Ferrer I; Hernández I; Boada M; Llorente A; Rey MJ; Cardozo A; Ezquerra M; Puig B
    Acta Neuropathol; 2003 Nov; 106(5):419-35. PubMed ID: 12955398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sporadic four-repeat tauopathy with frontotemporal lobar degeneration, Parkinsonism, and motor neuron disease: a distinct clinicopathological and biochemical disease entity.
    Fu YJ; Nishihira Y; Kuroda S; Toyoshima Y; Ishihara T; Shinozaki M; Miyashita A; Piao YS; Tan CF; Tani T; Koike R; Iwanaga K; Tsujihata M; Onodera O; Kuwano R; Nishizawa M; Kakita A; Ikeuchi T; Takahashi H
    Acta Neuropathol; 2010 Jul; 120(1):21-32. PubMed ID: 20140439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between histopathological features of progressive supranuclear palsy and disease duration.
    Josephs KA; Mandrekar JN; Dickson DW
    Parkinsonism Relat Disord; 2006 Mar; 12(2):109-12. PubMed ID: 16337422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inferior olivary hypertrophy is uncommon in progressive supranuclear palsy.
    Katsuse O; Dickson DW
    Acta Neuropathol; 2004 Aug; 108(2):143-6. PubMed ID: 15235807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of triple immunohistochemistry to characterize amyloid plaque-associated inflammation in brains with Alzheimer's disease.
    Dandrea MR; Reiser PA; Gumula NA; Hertzog BM; Andrade-Gordon P
    Biotech Histochem; 2001 Mar; 76(2):97-106. PubMed ID: 11440311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Arai T; Ikeda K; Akiyama H; Tsuchiya K; Iritani S; Ishiguro K; Yagishita S; Oda T; Odawara T; Iseki E
    Acta Neuropathol; 2003 May; 105(5):489-98. PubMed ID: 12677450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.